Page 5 of 17

PE5.2 | Breath Holding Spells — SDL Guide (Part 2)

Management and Prognosis

The cornerstone of management for breath-holding spells is parental education and reassurance, which is both the primary intervention and the most difficult skill to perform well. Parents who have witnessed an episode are invariably terrified and often convinced their child has epilepsy or has nearly died. Taking time to explain the mechanism clearly, using a simple diagram if helpful, dramatically reduces parental anxiety and reduces the morbidity of this benign condition. The management strategy differs for the two types and is stratified by the presence or absence of iron deficiency and the frequency and severity of spells. For the majority of children with typical BHS and no iron deficiency, the entire management consists of education, reassurance, and behavioural guidance — no pharmacological therapy is required. The small subset with iron deficiency benefit from supplementation, and the rare child with severe pallid BHS may need atropine.

Parental counselling — key messages to convey:
- Breath-holding spells are involuntary; the child is not manipulating the parents or choosing to hold their breath.
- The spell is self-limiting: the child will always recover spontaneously — the brain's own hypoxic drive terminates the spell.
- No child has died from a breath-holding spell.
- The spells resolve spontaneously in >90% of children by age 5–6 years.
- During a spell: lay the child on their side (recovery position) on the floor, do not restrain, do not put anything in the mouth, stay calm, time the episode.
- Do not attempt to revive the child by shaking, splashing water, or artificial respiration — these are not needed and may create more fear.

Iron supplementation:
All children with BHS should be screened for iron deficiency (full blood count, serum ferritin). If iron deficiency is confirmed, oral iron supplementation (elemental iron 3–6 mg/kg/day for 3 months) should be prescribed, even in the absence of frank anaemia. Multiple RCTs demonstrate a significant reduction in BHS frequency with iron therapy in iron-deficient children. Dietary counselling to improve iron intake (iron-rich foods, vitamin C to enhance absorption) should accompany supplementation.

Pharmacological treatment:
For the vast majority of children with typical BHS, pharmacological treatment is not indicated. Specific exceptions:
- Pallid BHS — severe or very frequent episodes causing significant distress or injury: atropine (0.01 mg/kg oral, weight-based) can be considered to block the vagal mechanism; this is rarely needed.
- Anti-epileptic drugs are NOT indicated for BHS and should not be prescribed.

Behavioural strategies:
For cyanotic BHS triggered by tantrums, firm limit-setting and consistent parental responses reduce the frequency of triggering episodes over time. Parents should avoid reinforcing tantrums by giving in to demands after spells, as this perpetuates the behaviour cycle (even though the spells themselves are involuntary).

Prognosis:
- Cyanotic BHS: resolves spontaneously in >90% by age 5–6 years.
- Pallid BHS: resolves by school age in most, but a small proportion (~15%) develop vasovagal syncope in adolescence — this is benign and managed differently.
- No increased risk of epilepsy in children with classic BHS and a normal EEG.

Self-Assessment

You have now covered the essential knowledge base for breath-holding spells: the two clinical types, their distinct mechanisms, the diagnostic approach based on clinical history, the limited role of investigations, and the management centred on reassurance and iron therapy. The most important intellectual step in managing BHS is the ability to make a confident clinical diagnosis without over-investigating, and to communicate that confidence to an anxious family. This competency is tested frequently in clinical examinations through vignettes requiring you to distinguish BHS from epilepsy, identify the correct type, and choose the appropriate management. The checklist below consolidates the high-yield factual anchors from this module — review each point carefully and ensure you can explain it in your own words before proceeding to the self-assessment questions.

• BHS occur between 6 months and 5 years; peak at 2 years; family history in ~25–30%.
• Cyanotic (~85%): emotional trigger → crying → expiratory apnoea → cyanosis → LOC; pallid (~15%): pain/shock → vagal bradycardia/asystole → pallor → syncope.
• Diagnosis is clinical; EEG between episodes is normal.
• Distinguishing feature from epilepsy: BHS always has a trigger and a preceding cry (cyanotic type); NO postictal confusion.
• Check iron studies in all children with BHS; iron supplementation reduces frequency if iron deficient.
• Atropine for severe/frequent pallid BHS only; no anti-epileptic drugs for BHS.
• Prognosis: >90% resolve spontaneously by age 5–6 years.